DEVON, Pa. (AP) — DEVON, Pa. (AP) — Zynerba Pharmaceuticals Inc. (ZYNE) on Tuesday reported a loss of $8 million in its fourth quarter.
On a per-share basis, the Devon, Pennsylvania-based company said it had a loss of 18 cents.
For the year, the company reported a loss of $35 million, or 82 cents per share.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ZYNE at https://www.zacks.com/ap/ZYNE